Prospective application of aptamer-based assays and therapeutics in bloodstream infections.

Prospective application of aptamer-based assays and therapeutics in bloodstream infections. Mini Rev Med Chem. 2020 Feb 11;: Authors: Li W Abstract Sepsis is still a severe health problem worldwide with high morbidity and mortality. Blood bacterial culture remains the gold standard for detection of pathogenic bacteria in bloodstream infections but time-consuming and both of the sophisticated equipment and well-trained personnel are required. Immunoassays and genetic diagnosis are expensive and limited to specificity and sensitivity. Aptamers are single-stranded deoxyribonucleic acid (ssDNA) and ribonucleic acid (RNA) oligonucleotide or peptide sequence generated in vitro based on binding affinity of aptamer-target by a process known as Systematic Evolution of Ligands by Exponential Enrichment (SELEX). By taking several advantages over monoclonal antibodies and other conventional small-molecule therapeutics, such as high specificity and affinity, negligible batch-to-batch variation, flexible modification and production, thermal stability, low immunogenicity and lack of toxicity, aptamers are presently becoming promising novel diagnostic and therapeutic agents. This review describes prospective application of aptamer-based laboratory diagnostic assays and therapeutics for pathogenic bacteria and toxins in bloodstream infections. PMID: 32048971 [PubMed - as supplied by publisher]
Source: Mini Reviews in Medicinal Chemistry - Category: Chemistry Authors: Tags: Mini Rev Med Chem Source Type: research